FDA Inspection 1222303 — Greiner Bio-One North America, Inc.

Greiner Bio-One North America, Inc. — FEI 3001451379

The FDA completed an inspection of Greiner Bio-One North America, Inc. on Sep 14, 2023 in Monroe, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 14, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Monroe, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.